尿液糖蛋白组在泌尿系统癌症诊断中的研究进展

滕洪明; 逄越; 李庆伟

doi:10.13201/j.issn.1001-1420.2021.04.015

尿液糖蛋白组在泌尿系统癌症诊断中的研究进展

- 1. 辽宁师范大学生命科学学院(辽宁大连, 116081);
- 2. 辽宁师范大学七鳃鳗研究中心
基金项目:
国家自然科学基金项目(No:31772884)

辽宁省海洋与渔业厅科研项目(No:201805)

大连市科技创新基金项目(No:2018J12SN079)

辽宁省科技项目(No:2019-MS-218)

详细信息

通讯作者: 李庆伟,E-mail:liqw@263.com

中图分类号: R737

收稿日期: 2020-05-03

Advances in the application of urine glycoproteomics in the clinical diagnosis of urinary system cancer

- 1. School of Life Science, Liaoning Normal University, Dalian, Liaoning, 116081, China;
- 2. Lamprey Research Center, Liaoning Normal University

More Information

Corresponding author: LI Qingwei, E-mail: liqw@263.com

Received Date: 03 May 2020

摘要

摘要: 泌尿系统肿瘤患者基数大,恶性程度高,术后易复发,诊断方法有限,发展舒适、准确的癌症检查手段,一直是临床关注的焦点问题。尿液作为生物标志物来源进行筛查,被越来越多地开发和利用,尿液糖蛋白用于诊断泌尿系统癌症的研究甚少。尿液可以直接接触泌尿系统实体肿瘤,肿瘤分泌的特异性蛋白进入尿液,患者尿液样本便于足量多次收集,尿液蛋白质组技术以及糖基化修饰蛋白质组研究的快速发展,为我们利用尿液研究癌症诊断提供了便利的条件。本文系统总结了肿瘤微环境驱动肿瘤糖蛋白标志物的改变和尿液糖蛋白质组研究的主要进展,重点聚焦泌尿系统肿瘤患者尿液糖蛋白质组在临床肿瘤标志物诊断和预后的应用方向,以期为利用尿液糖基化修饰蛋白质组筛选生物标记物,临床诊断癌症和治疗的基础研究提供理论依据。
- 液体活检 /
- 糖蛋白组 /
- 泌尿系统肿瘤 /
- 诊断 /
- 生物标记物
Abstract: Patients with urinary system tumors have a large base, a high degree of malignancy, easy recurrence and limited diagnosis. Developing comfortable and accurate tumor examination methods has been the subject of clinical attention. Urine, as a biomarker source for screening, has been developed and utilized more and more. However, there are few studies in the diagnosis of urinary tumors by urine glycoproteins. Urine can be located in direct contact with solid tumors of the urinary system, and specific proteins secreted by tumors enter into urine. A sufficient number of patient urine samples can be collected at multiple times. The rapid development of urine proteomics technology and glycosylation modified proteomics provides convenient conditions for us to study cancer diagnosis by urine. This review systematically summarizes the changes of tumor glycoprotein markers driven by tumor microenvironment and the main ideas of urine glycoproteins research were systematically summarized. The application direction of urine glycoproteins in the diagnosis and prognosis of clinical tumor markers was emphatically expounded in order to screen biomarkers by using urine glycosylated modified proteome and provide help for basic research of clinical diagnosis and treatment of cancer.
- liquid biopsy /
- glycoproteomics /
- urinary system cancer /
- diagnosis /
- biomarker

HTML全文

参考文献(47)

[1]	Mathai RA,Vidya R,Reddy BS,et al.Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors:Implications in the Precision Oncology[J].J Clin Med,2019,8(3):373.
[2]	Mari R,Mamessier E,Lambaudie E,et al.Liquid Biopsies for Ovarian Carcinoma:How Blood Tests May Improve the Clinical Management of a Deadly Disease[J].Cancers(Basel),2019,11(6):774.
[3]	Marcuello M,Vymetalkova V,Neves R,et al.Circulating biomarkers for early detection and clinical management of colorectal cancer[J].Mol Aspects Med,2019,69:107-122.
[4]	Huang CC,Du M,Wang L.Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer[J].Cancers(Basel),2019,11(6):805.
[5]	Rood J,Jamalpoor A,van Hoppe S,et al.Extrahepatic metabolism of ibrutinib[J].Invest New Drugs,2021,39(1):1-14.
[6]	Park GW,Lee JW,Lee HK,et al.Classification of Mucin-Type O-Glycopeptides Using Higher-Energy Collisional Dissociation in Mass Spectrometry[J].Anal Chem,2020,92(14):9772-9781.
[7]	Smalley H,Rowe JM,Nieto F,et al.Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth[J].Cancer Lett,2020,495:66-75.
[8]	顾燕琴,何屹,侯岩松,等.尿液前列腺小题外泄蛋白作为诊断指标在Ⅲ型前列腺炎的应用价值[J].临床泌尿外科杂志,2019,34(3):218-221.
[9]	Coady A,Ramos AR,Olson J,et al.Tamm-Horsfall Protein Protects the Urinary Tract against Candida albicans[J].Infect Immun,2018,86(12):e00451-18.
[10]	Wu D,Lv J,Zhao R,et al.PSCA is a target of chimeric antigen receptor T cells in gastric cancer[J].Biomark Res,2020,8:3.
[11]	Koivisto MK,Tervahartiala M,Kenessey I,et al.Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer[J].Carcinogenesis,2019,40(1):84-92.
[12]	Janisch F,D'Andrea D,Iwata T,et al.The prognostic value of the urokinase-plasminogen activator system(uPA)in bladder cancer patients treated with radical cystectomy(RC)[J].Urol Oncol,2020,38(5):423-432.
[13]	Azevedo R,Soares J,Gaiteiro C,et al.Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer[J].Talanta,2018,184:347-355.
[14]	Liu L,Wang Q,Mao J,et al.Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells[J].Chem Biol Interact,2018,296:145-153.
[15]	Zhou X,Yang G,Guan F.Biological Functions and Analytical Strategies of Sialic Acids in Tumor[J].Cells,2020,9(2):273.
[16]	Meril S,Harush O,Reboh Y,et al.Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells[J].Mol Carcinog,2020,59(7):713-723.
[17]	Casey SC,Amedei A,Aquilano K,et al.Cancer prevention and therapy through the modulation of the tumor microenvironment[J].Semin Cancer Biol,2015,35 Suppl(Suppl):S199-S223.
[18]	Ye B,Skates S,Mok SC,et al.Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine[J].Clin Cancer Res,2006,12(2):432-441.
[19]	Adachi J,Kumar C,Zhang Y,et al.The human urinary proteome contains more than 1500 proteins,including a large proportion of membrane proteins[J].Genome Biol,2006,7(9):R80.
[20]	Carvalho LB,Capelo-Martínez JL,Lodeiro C,et al.Snap-heated freeze-free preservation and processing of the urine proteome using the combination of stabilizor-based technology and filter aided sample preparation[J].Anal Chim Acta,2019,1076:82-90.
[21]	Nnodum B,Dudley L.Class IV Lupus Nephritis in the Setting of Serologically Quiescent Disease and Normal Urine Sediment in a Patient with Late-Onset Systemic Lupus Erythematosus[J].Case Rep Rheumatol,2019,2019:1219529.
[22]	Li Y,Hu Q,Li C,et al.PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease[J].J Clin Invest,2019,129(3):1129-1151.
[23]	Zuiverloon TC,Beukers W,van der Keur KA,et al.Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer:the European FP7 UROMOL project[J].J Urol,2013,189(5):1945-1951.
[24]	Thomas CE,Sexton W,Benson K,et al.Urine collection and processing for protein biomarker discovery and quantification[J].Cancer Epidemiol Biomarkers Prev,2010,19(4):953-959.
[25]	Rosen EM,Mínguez-Alarcón L,Meeker JD,et al.Urinary oxidative stress biomarker levels and reproductive outcomes among couples undergoing fertility treatments[J].Hum Reprod,2019,34(12):2399-2409.
[26]	Lin M,Tang J,Ma S,et al.Insights into biomonitoring of human exposure to polycyclic aromatic hydrocarbons with hair analysis:A case study in e-waste recycling area[J].Environ Int,2020,136:105432.
[27]	Blyuss O,Zaikin A,Cherepanova V,et al.Development of PancRISK,a urine biomarker-based risk score for stratified screening of pancreatic cancer patients[J].Br J Cancer,2020,122(5):692-696.
[28]	Halim A,Nilsson J,Rüetschi U,et al.Human urinary glycoproteomics;attachment sites specific analysis of N-and O-linked glycosylations by CID and ECD[J].Mol Cell Proteomics,2012,11(4):M111.013649.
[29]	Miyake M,Goodison S,Giacoia EG,et al.Influencing factors on the NMP-22 urine assay:an experimental model[J].BMC Urol,2012,12:23.
[30]	Visnjar T,Romih R,Zupancic D.Lectins as possible tools for improved urinary bladder cancer management[J].Glycobiology,2019,29(5):355-365.
[31]	Zhu J,Huang J,Zhang J,et al.Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis[J].J Proteome Res,2020,19(8):3452-3466.
[32]	Miyake M,Hori S,Morizawa Y,et al.Collagen type IV alpha 1(COL4A1) and collagen type XIII alpha 1(COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder[J].Oncotarget,2017,8(22):36099-36114.
[33]	Belczacka I,Pejchinovski M,Krochmal M,et al.Urinary Glycopeptide Analysis for the Investigation of Novel Biomarkers[J].Proteomics Clin Appl,2019,13(3):e1800111.
[34]	Miyake M,Morizawa Y,Hori S,et al.Diagnostic and prognostic role of urinary collagens in primary human bladder cancer[J].Cancer Sci,2017,108(11):2221-2228.
[35]	Darula Z,Pap Á,Medzihradszky KF,et al.Extended Sialylated O-Glycan Repertoire of Human Urinary Glycoproteins Discovered and Characterized Using Electron-Transfer/Higher-Energy Collision Dissociation[J].J Proteome Res,2019,18(1):280-291.
[36]	Elie-Caille C,Lascombe I,Péchery A,et al.Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure[J].Mol Cell Biochem,2020,471(1-2):113-127.
[37]	Gao L,Meng J,Zhang M,et al.Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer[J].DNA Cell Biol,2020,39(6):1072-1089.
[38]	Yan R,Li X,Song J,et al.Metabolic Changes Precede Radiation-Induced Cardiac Remodeling in Beagles:Using Noninvasive 18F-FDG(18F-Fludeoxyglucose)and 13N-Ammonia Positron Emission Tomography/Computed Tomography Scans[J].J Am Heart Assoc,2020,9(18):e016875.
[39]	Yan KK,Wang X,Lam W,et al.Radiomics analysis using stability selection supervised component analysis for right-censored survival data[J].Comput Biol Med,2020,124:103959.
[40]	Hanke M,Dubois J,Kausch I,et al.Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA[J].PLoS One,2020,15(7):e0229193.
[41]	Braun DA,Hou Y,Bakouny Z,et al.Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma[J].Nat Med,2020,26(6):909-918.
[42]	Kato T,Takeda Y,Ito H,et al.GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma[J].Tohoku J Exp Med,2019,249(3):203-212.
[43]	Sharan B,Chiliveru S,Bagga J,et al.Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy(APCEDEN):A case report[J].Medicine(Baltimore),2020,99(8):e18889.
[44]	Wroclawski ML,Baccaglini W,Pazeto CL,et al.Bladder pseudo-tumor:case report of vesical tamm-horsfall protein deposit[J].Int Braz J Urol,2020,46(3):477-480.
[45]	Chen Ruohua,Wang Yining,Shi Yiping et al.Diagnostic value of F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative Ga-PSMA PET/CT[J].Eur J Nucl Med Mol Imaging,2021.
[46]	Peng J,Jiang H,Guo J,et al.CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD[J].Biomed Res Int,2020,2020:7638975.
[47]	闫厚煜,邢金春,张开颜,等.前列腺癌的早期诊断研究进展[J].临床泌尿外科杂志,2020,35(3):242-246.